Xigduo XR Injury Lawyers
Have you or a loved one suffered an injury due to taking the diabetes medication Xigduo XR? If so you may be entitled to benefits as well as monetary compensation. Speaking with, and ultimately retaining, a skilled Xigduo XR injury attorney is a wise move.
Please contact our Xigduo XR injury lawyers here for a free consultation. They handle Xigduo lawsuit cases, which are mass tort claims, on a contingency fee basis which means they charge no legal fees of any kind unless they win for you.
What is Xigduo XR?
Xigduo XR, manufactured by AstraZeneca, combines the new generation diabetes drug Farxiga with metformin. Xigduo is a combination of two oral antihyperglycemic medications used to improve glycemic control in adults with Type 2 diabetes mellitus. It contains dapagliflozin and metformin. Dapagliflozin works by helping the kidneys get rid of glucose in the blood stream. Metformin works by lowering glucose production in the liver. It also causes the intestines to absorb less glucose.
This new drug is part of a class of medications known as SGLT2 inhibitors. SGLT2 inhibitors impact the normal functioning of the kidneys. Such inhibitors cause more sugar to be excreted in the urine. Controlling high blood sugar helps prevent kidney damage, blindness, loss of limbs, and sexual function problems. The proper control of diabetes can also lessen a person’s risk of developing a stroke or heart attack. Common side effects of Xigduo include the following:
- Lactic acidosis
- Kidney problems
- Urinary tract infection
- Low blood sugar (hypoglycemia)
- Vaginal yeast infection
- Bladder cancer
- Yeast infection of the penis
In May 2015, the Food and Drug Administration (FDA) issued a drug safety warning regarding the potential link between Xigduo and ketoacidosis and other conditions involving the buildup of acid in the blood. Such conditions have resulted in serious health complications in patients. The FDA warned patients experiencing symptoms of ketoacidosis to seek immediate medical assistance. Common symptoms of ketoacidosis while taking Xigduo include the following:
- Shortness of breath
- Nausea or vomiting
- Severe abdominal pain
- Fatigue and confusion
- Frequent urination
- Muscle stiffness or aches
The FDA has recommended that patients who take SGLT2 inhibitor medication should monitor themselves for signs of ketoacidosis. Ketones can be detected with a urine test. Do not stop taking Xigduo without first consulting your doctor.
Our Xigduo injury lawyers represent patients who have developed the above referenced symptoms after taking Xigduo. Our law office is reviewing lawsuits that allege the drug manufacturer failed to provide adequate warning signs at the time Xigduo was marketed to consumers.
To date, no recall has been made for Xigduo in the U.S. A black box warning regarding lactic acidosis has been issued on Xigduo’s labeling.
Injury Lawyers Investigating Xigduo Lawsuits
Patients harmed by Xigduo due to ketoacidosis may be entitled to compensation for damages arising from the medical condition. Our Xigduo injury lawyers are currently handling individual injury claims. Contact us for a consultation. Settlements for Xigduo are expected to be substantial due to the serious nature of medical complications. Depending on the extent of your injury, you may be entitled to the following types of compensation:
- Medical expenses
- Pain and suffering
- Lost wages
- Emotional distress
In order to prevail in a product liability action for damages against AstraZeneca, you will have to prove that Xigduo was the direct and actual cause of you developing DKA and resulting complications. Do not delay in filing a claim. Doing so can bar you from recovering compensation for damages. Contact us today for a free consultation. We can provide you with legal guidance and advice on how to proceed in filing a claim against AstraZeneca.
No matter what state you were injured in our team of Xigduo lawsuit lawyers and wrongful death attorneys can help as they serve all 50 states and Washington D.C. including: Alabama, Alaska, Arkansas, California, Colorado, Connecticut, Delaware, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington D.C., West Virginia and Wisconsin.